Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Benitec Biopharma Inc.

    NASDAQ: BNTC · Real-Time Price · USD
    11.29
    -1.06 (-8.58%)
    At close: Jun 27, 2025, 3:59 PM
    11.35
    0.58%
    After-hours: Jun 27, 2025, 05:50 PM EDT

    Benitec Biopharma Statistics

    Share Statistics

    Benitec Biopharma has 26.25M shares outstanding. The number of shares has increased by 172.16% in one year.

    Shares Outstanding

    n/a
    		 26.25M

    Shares Change (YoY)

    n/a
    		 172.16%

    Shares Change (QoQ)

    n/a
    		 9.81%

    Owned by Institutions (%)

    n/a
    		 86.06%

    Shares Floating

    n/a
    		 24.55M

    Failed to Deliver (FTD) Shares

    n/a
    		 393

    FTD / Avg. Volume

    n/a
    		 0.63%

    Short Selling Information

    The latest short interest is 445.55K, so 1.74% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 445.55K

    Short % of Shares Out

    n/a
    		 1.74%

    Short % of Float

    n/a
    		 3.25%

    Short Ratio (days to cover)

    n/a
    		 10.32

    Valuation Ratios

    The PE ratio is -3.43 and the forward PE ratio is -5.31. Benitec Biopharma's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -3.43

    Forward PE

    n/a
    		 -5.31

    PS Ratio

    n/a
    		 344.9

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 1.58

    P/FCF Ratio

    n/a
    		 -3.8

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Benitec Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.49, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 10.49

    Quick Ratio

    n/a
    		 10.49

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -24.88

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $13,500

    Profits Per Employee

    n/a
    		 $-1,359,437.5

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -619K

    Effective Tax Rate

    n/a
    		 2.77%

    Stock Price Statistics

    The stock price has increased by 75.18% in the last 52 weeks. The beta is 0.44, so Benitec Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.44

    52-Week Price Change

    n/a
    		 75.18%

    50-Day Moving Average

    n/a
    		 14.42

    200-Day Moving Average

    n/a
    		 12

    Relative Strength Index (RSI)

    n/a
    		 32.18

    Average Volume (20 Days)

    n/a
    		 62,596

    Income Statement

    In the last 12 months, Benitec Biopharma had revenue of 216K and earned -21.75M in profits. Earnings per share was -2.68.

    Revenue

    n/a
    		 216K

    Gross Profit

    n/a
    		 108K

    Operating Income

    n/a
    		 -22.49M

    Net Income

    n/a
    		 -21.75M

    EBITDA

    n/a
    		 -22.49M

    EBIT

    n/a
    		 -21.75M

    Earnings Per Share (EPS)

    n/a
    		 -2.68
    Full Income Statement

    Balance Sheet

    The company has 50.87M in cash and 284K in debt, giving a net cash position of 50.58M.

    Cash & Cash Equivalents

    n/a
    		 50.87M

    Total Debt

    n/a
    		 284K

    Net Cash

    n/a
    		 50.58M

    Retained Earnings

    n/a
    		 -190.26M

    Total Assets

    n/a
    		 105.21M

    Working Capital

    n/a
    		 96.98M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -19.4M and capital expenditures -179K, giving a free cash flow of -19.58M.

    Operating Cash Flow

    n/a
    		 -19.4M

    Capital Expenditures

    n/a
    		 -179K

    Free Cash Flow

    n/a
    		 -19.58M

    FCF Per Share

    n/a
    		 -1.91
    Full Cash Flow Statement

    Margins

    Gross margin is 50%, with operating and profit margins of -10412.04% and -10069.91%.

    Gross Margin

    n/a
    		 50%

    Operating Margin

    n/a
    		 -10412.04%

    Pretax Margin

    n/a
    		 -10356.48%

    Profit Margin

    n/a
    		 -10069.91%

    EBITDA Margin

    n/a
    		 -10412.04%

    EBIT Margin

    n/a
    		 -10412.04%

    FCF Margin

    n/a
    		 -9065.74%

    Dividends & Yields

    BNTC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BNTC is $20, which is 61.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $20

    Price Target Difference

    n/a
    		 61.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 26, 2023. It was a backward split with a ratio of 1:17.

    Last Split Date

    n/a
    		 Jul 26, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:17

    Scores

    Altman Z-Score

    n/a
    		 29.79

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist